Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urokinase for Pediatric Pleural Empyema
NCT03716375Unknown
- Sponsor
- Beijing Children's Hospital
- Start
- Nov 2018
- Primary completion
- Apr 2019
- Modality
- Therapeutic Enzymes
01
Overview
Randomised, open-label trial of urokinase in pleural empyema (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Length of hospital stay at 2 weeks. Status: unknown.
02
Drugs
urokinase
03
Conditions
pleural empyema
Beyond the preview
Go deeper on NCT03716375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03716375.